Spanish Red Biotech Pipeline

IRYCIS

Aptamers against MNK1 for the treatment of breast cancer

Type: Others
Therapeutic area: Cancer
Indication: Aptamers against MNK1 for the treatment of breast cancer
Phase: 2Preclinical Validation, 1R+D
Studies location: